Paradigm Biocapital Advisors LP 13F Portfolio

EntityCategoryQoQ AUM ChangeAUM (13F)# of HoldingsPerformance RankEquities Trend
PB
Paradigm Biocapital Advisors LP
Institutional Filer 31.04%$4.89B35

Current Portfolio Holdings

Showing all 35 reported positions by value

#StockCompany NameSectorShares HeldMarket Value% of Portfolio
1ACLXArcellx, Inc.Healthcare5.8M$663.0M13.55%
2RVMDRevolution Medicines, Inc.Healthcare6.7M$647.3M13.23%
3NUVLNuvalent, Inc.Healthcare5.3M$545.5M11.15%
4PCVXVaxcyte, Inc.Healthcare4.8M$278.5M5.69%
5EWTXEdgewise Therapeutics, Inc.Healthcare7.4M$232.0M4.74%
6GMABGenmab A/SHealthcare8.0M$213.8M4.37%
7INSMInsmed IncorporatedHealthcare1.3M$205.1M4.19%
8TARSTarsus Pharmaceuticals, Inc.Healthcare2.6M$179.7M3.67%
9BLTEBelite Bio, IncHealthcare1.1M$177.7M3.63%
10ERASErasca, Inc.Healthcare10.4M$168.2M3.44%
11CNTACentessa Pharmaceuticals plcHealthcare3.6M$142.0M2.90%
12OLMAOlema Pharmaceuticals, Inc.Healthcare8.0M$119.6M2.44%
13TERNTerns Pharmaceuticals, Inc.Healthcare2.2M$116.9M2.39%
14ORKAOruka Therapeutics, Inc.Healthcare2.3M$113.8M2.33%
15APGEApogee Therapeutics, Inc.Healthcare1.3M$113.5M2.32%
Showing 1 to 15 of 35 holdings